한국어
Home › Companies › CXI Healthcare Technology Group

CXI Healthcare Technology Group

씨엑스아이 · 900120 · KOSDAQ
Filings, last 12 months
98
Supply contracts
1
Insider reports
9
Share & bond issues
6

At a glance

CXI Healthcare Technology Group filed 98 disclosures in the last 12 months, including 11 5% holder, 9 insider, 6 issuance, 2 m&a and 1 contract. The most recent key filing was on Oct 13.

Revenue for 2025 was ₩297M, down 21.2% on 2024. Operating margin was 16.9% against 27.2% a year earlier. Debt was 1% of equity at year end.

Of 5 recent 5%+ holder reports, 4 raised and 1 cut a stake; the largest stake reported was 37.44% on Aug 31.

From the 2025 annual report

No cash dividend was paid for 2025.

Largest shareholder

CHEN AI ZHU holds 7.03%; with 0 related parties the group holds 7.03% of common shares at year end.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

1 new supply contract worth 14% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary

2023
Revenue ₩377M
Op. profit ₩37.6M
Debt/equity 1%
2024
Revenue ₩376.9M
Op. profit ₩102.4M
Debt/equity 1%
2025
Revenue ₩297M
Op. profit ₩50.2M
Debt/equity 1%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

5%+ holder reports

8/31Stake 24.18%+13.98pp
8/31Stake 21.18%+21.18pp
8/31Stake 37.44%-8.59pp
7/16Stake 10.20%+10.20pp
7/16Stake 10.32%+10.32pp

Key filings

10/22M&AAmendedA ₩60.6B deal, equal to 12.3% of total assets.₩60.6B
10/19M&AAmendedStake acquisition/disposal
10/13M&AStake acquisition/disposal
10/2ExchangeTrading halt
8/31InsiderOther change10%+ shareholder's holding rose by 1,040,000 sh (share consolidation/split, rights offering).+1,040,000 sh
8/315% holderA major holder's stake rose from 10.20% to 24.18% (rights offering).24.18%
8/31InsiderOther change10%+ shareholder's holding rose by 2,400,000 sh (rights offering).+2,400,000 sh
8/315% holderNew 5%A major holder's stake rose from 0.00% to 21.18% (rights offering).21.18%
8/31InsiderOther changeCEO's holding fell by 844,248 sh (share consolidation/split, rights offering).-844,248 sh
8/315% holderA major holder's stake fell from 46.03% to 37.44% (rights offering).37.44%
8/20ExchangeSpin-off / split
8/19M&AAmendedA ₩313B deal, equal to 63.4% of total assets.₩313B
7/27ExchangeAdministrative issue
7/27ContractWorth 13.6% of last year's revenue, over about 12 months.₩7.3B
7/21IssuanceRights offeringIssuing 8,000,000 sh of new shares, equal to 240% of existing shares.₩48B
7/16InsiderInsider ownership report
7/165% holderNew 5%A major holder's stake rose from 0.00% to 10.20% (rights offering).10.20%
7/16InsiderInsider ownership report
7/165% holderNew 5%A major holder's stake rose from 0.00% to 10.32% (rights offering).10.32%
7/16InsiderInsider ownership report
7/165% holderNew 5%A major holder's stake rose from 0.00% to 13.81% (rights offering).13.81%
7/16M&AStake acquisition/disposal
7/1IssuanceRights offeringIssuing 5,500,000 sh of new shares, equal to 49.2% of existing shares.₩6.6B
6/23ExchangeCapital reduction
6/17InsiderInsider ownership report
6/175% holderA major holder's stake rose from 22.17% to 46.03% (rights offering).46.03%
6/11IssuanceAmendedRights offeringIssuing 3,700,000 sh of new shares, equal to 49.5% of existing shares.₩7.2B
6/105% holderA major holder's stake rose from 6.73% to 6.73% (share consolidation/split).6.73%
6/10InsiderInsider ownership report
6/105% holderA major holder's stake rose from 22.17% to 22.17% (share consolidation/split).22.17%
6/4IssuanceRights offering
5/7ExchangeSpin-off / split
4/6IssuanceAmendedCapital reductionCapital reduction of 80%.80%
4/3IssuanceAmendedCapital reduction
4/2IssuanceCapital reduction
3/23IssuanceCapital reduction
3/165% holderAmendedNew 5%A major holder's stake rose from 0.00% to 6.73% (new report).6.73%
3/125% holderReport of 5%+ holding
3/12InsiderInsider ownership report
3/125% holderA major holder's stake rose from 7.68% to 22.17% (stock option).22.17%
3/9IssuanceAmendedRights offeringIssuing 7,290,519 sh of new shares, equal to 24.3% of existing shares.₩5.3B
3/5IssuanceAmendedRights offering
2/12IssuanceRights offering

Other filings

10/28Annual report
10/28Filing
10/28Shareholders' meeting
10/22Filing
10/20Filing
10/20Shareholders' meeting
10/20Audit report
10/14Insider trading plan
10/8Filing
10/8Shareholders' meeting
10/8Change in revenue or profit of 30%+
10/8Change in revenue or profit of 30%+
10/8Change in revenue or profit of 30%+
10/8Shareholders' meeting
10/7Filing
8/28Rights offering
8/27Filing
8/27Filing
8/19Stake acquisition/disposal
8/11Filing
8/11Shareholders' meeting
8/7Shareholders' meeting
8/7Shareholders' meeting
7/27Shareholders' meeting
7/21Insider trading plan
7/21Filing
7/21Shareholders' meeting
7/15Stake acquisition/disposal
7/9Rights offering
7/2Filing
7/2Shareholders' meeting
6/12Filing
6/12Rights offering
6/4Capital reduction
6/2Filing
6/1Quarterly report
5/21Filing
5/21Filing
4/7Shareholders' meeting
3/30Tangible asset deal

Links open the original filing on DART, in Korean.